June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Single cell RNA-Sequencing of aqueous immune cells reveals a spectrum of ocular immune responses in human uveitis
Author Affiliations & Notes
  • Lynn Hassman
    Department of Ophthalmology and Visual Science, Washington University in St Louis, St Louis, Missouri, United States
  • Footnotes
    Commercial Relationships   Lynn Hassman Priovant Therapeutics, EyePoint Pharmaceuticals, Code C (Consultant/Contractor), Priovant Therapeutics, Code R (Recipient)
  • Footnotes
    Support  1K08EY033045; departmental unrestricted funds from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1293. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lynn Hassman; Single cell RNA-Sequencing of aqueous immune cells reveals a spectrum of ocular immune responses in human uveitis. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1293.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Non-infectious uveitis causes 10% of blindness in the US and disproportionately affects working-aged people, making it a significant cause of vision-related disability. Importantly, uveitis is a heterogeneous group of unique disease entities that are currently defined by clinical features rather than molecular mechanisms. As such the treatment approach is empiric and individual drugs fail 20-50% of patients. Alternatively, more precise molecular characterization of uveitis subtypes should provide pathophysiologic insight with therapeutic potential. Single-cell RNA-Sequencing (scRNA-Seq) facilitates deep, unbiased immune cell profiling of even very small samples, making it ideal for analyzing immune cell infiltrates in the anterior chamber. In this study, we set out to capitalize on the unbiased molecular characterization of individual ocular immune cells afforded by scRNA-Seq to 1) identify pathophysiologic mechanisms with therapeutic potential in uveitis and 2) advance molecular classification of clinical uveitis entities. We found that aqueous immune cell infiltrates differed significantly between patients and correlated with specific clinical phenotypes. Specifically, we found clonally expanded T and B cells, strong evidence of antigen-driven immune responses, in patients with granulomatous uveitis; however, patients with HLA-B27-associated uveitis had aqueous infiltrates dominated by unconventional T cells and myeloid cells.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×